Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells
- 17 December 2012
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 43 (2) , 212-222
Abstract
Summary: Background: Plasticity of CD4+ lymphocyte Th17/regulatory T cell (Treg) subsets is involved in the pathogenesis of chronic airway inflammatory diseases, such as asthma. Reversal of Th17/Treg cell balance towards Treg cells may be beneficial for the suppression of chronic Th2 cell‐mediated inflammatory diseases, such as asthma. However, the effect of the combination of corticosteroids and a statin on the ratio of Treg/Th17 cells is unknown.Objective: We investigated the in vitro effects of the combination of simvastatin and fluticasone propionate (FP) on the numbers of Treg and Th17 cells in asthmatic patients after co‐incubation with monocyte‐derived DCs (mDCs), and explored the underlying signalling pathways involved.Methods: Using flow cytometry, we determined the effects of FP and simvastatin on Treg/Th17 balance after co‐incubation of asthmatic CD4+ T cells with mDCs. We also measured the relevant Treg and Th17‐polarizing cytokines released from mDCs and also investigated the role of indoleamine 2, 3‐dioxygenase (IDO) in this response.Results: The combination of simvastatin and FP significantly increased Treg and concomitantly reduced Th17 cell numbers to a greater extent than FP or statin treatment alone. The enhancing effects of simvastatin on FP effects were mediated through the up‐regulation of indoleamine 2, 3‐dioxygenase and interleukin (IL)‐10, together with down‐regulation of IL‐6 and IL‐23 expression in mDCs.Conclusion: On the basis of this in vitro model of asthma, we suggest that the combination of a statin and a corticosteroid could augment the Treg/Th17 cell ratio and thus more effectively suppress airway inflammation in asthma patients. This may be particularly relevant in the treatment of severe asthma where Th17 cells are activated and linked to neutrophilic inflammation.Keywords
This publication has 58 references indexed in Scilit:
- IL-35 production by inducible costimulator (ICOS)–positive regulatory T cells reverses established IL-17–dependent allergic airways diseaseJournal of Allergy and Clinical Immunology, 2012
- Mechanisms of immunotherapy to aeroallergensClinical & Experimental Allergy, 2011
- Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanismProceedings of the National Academy of Sciences, 2010
- Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor‐β signal transductionImmunology, 2010
- Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthmaNature Medicine, 2008
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- Signal transduction pathways and transcriptional regulation in the control of Th17 differentiationSeminars in Immunology, 2007
- CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylationJournal of Experimental Medicine, 2007
- Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti–Tim-3 antibody in vivoJournal of Experimental Medicine, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006